Biotech Values

[drbio45]

Can you tell us more about why you like CRTX so much? I know they have an approved product with a large sales force, but the pipeline seems awfully thin. I'm looking at it, but didn't know the Prospect Partners. so thanks for that.

Zyflo is a drug that needs to be taken four times a day for asthma that Abbott developed. Singular needs to be taken once a day.

Zyflo works for severe asthma singulair only works for mild to moderate.

No one is going to take the drug 4 times a day. they make fill a prescription and try to use it twice a day but it won't work

on May 31 the recieved approval for the twice a day drug and if you have severe asthma I think you would take it to avoid asthma attacks. they just signed a deal with Dey which was just bought by Mylan. Dey will have 200 salespeople co promoting the drug but Critical will recognise 65 percent of the revenues. Critical will have 40 sales people. They pay for their own salses people so the economics are good for Critical. Dey received approval on a COPD drug in Early May sot critical will also be getting sales from that. Probably enough to pay for their sales force.

I don't need a deep pipeline because the stock is cheap and I think in their severe asthma maket it can be a 100 to 200 million dollar drug.

They also have an IV version of Zileuton which is going into trials for people going to the emergency room with asthma attacks. that has a chance to be a really nice drug.